Xanthomatosis, Cerebrotendinous

Explore clinical trials studying Xanthomatosis, Cerebrotendinous. Study availability and eligibility vary by location and protocol.

13 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Xanthomatosis, Cerebrotendinous trial results

Completed

NCT02275650

Conditions: Avitaminosis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Deficiency Diseases, +11 more
Locations: Päijät-Häme Central Hospital Lahdenkylä, Pirkanmaa, Finland

Tampere University Hospital Tampere, Pirkanmaa, Finland

Completed

NCT00439244

Conditions: Bone Diseases, Bone Diseases, Metabolic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations: Birmingham, Alabama, United States

Beverly Hills, California, United States

Novartis Investigative Site La Mesa, California, United States

Novartis Investigative Site Oakland, California, United States

View all 33 locations

Active, Not Recruiting

NCT03655223

Conditions: 17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations: RTI International Research Triangle Park, North Carolina, United States